MDT
Status-Quo-PlayerMedtronic
$88.00
+0.91%
as of 13 Apr
Power Core
Medtronic's moat is the only global medtech distribution and service infrastructure capable of delivering a full-spectrum device portfolio to hospitals in over 150 countries.
Direction of Movement
Lateral Movement With Selective Positive Signals Emerging
ROC 200
-1.5%
MDT
Medtronic
$88.00
+0.91%
as of 13 Apr
DCF Fair Value: $167.29
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solutions, rhythm management, surgery, coronary and renal denervation, mechanical circulatory support, peripheral vascular health, structural heart and aortic products; Diabetes, offering therapies and services for insulin-dependent individuals with Type 1 and Type 2 diabetes; Medical Surgical, encompassing surgical endoscopy and acute care and monitoring; and Restorative Therapies, covering cranial and spinal technologies, neuromodulation, neurovascular, pelvic health, gastric therapies, and ear, nose, and throat solutions. Medtronic plc produces innovative products such as implantable pacemakers, cardioverter-defibrillators, spinal cord stimulators, insulin pumps, and remote monitoring systems, serving patients in hospitals, homes, and surgical settings worldwide. Founded in 1949 and legally headquartered in Dublin, Ireland, with operational headquarters in Minneapolis, Minnesota, it focuses on advancing healthcare through minimally invasive therapies, disease management, and patient monitoring technologies in more than 150 countries.